Synthesis of Willardiine and 6-azawillardiine analogs: Pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes

Journal of Medicinal Chemistry

Volumn 40, Issue 22, 1997, Pages 3645-3650

  Jane, David E ^a   Hoo, Ken ^c   Kamboj, Raj ^c   Deverill, Michele ^c   Bleakman, David ^b   Mandelzys, Allan ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c NPS Pharmaceutical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAINIC ACID RECEPTOR; WILLARDIINE;

ALKYLATION; AMINO ACID SUBSTITUTION; ARTICLE; DRUG SYNTHESIS; ENANTIOMER; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR CLONING; NONHUMAN; RECEPTOR AFFINITY; SPINAL GANGLION; SYNAPTIC TRANSMISSION;

ALANINE; CELL LINE; EXCITATORY AMINO ACID AGONISTS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PYRIMIDINONES; RADIOLIGAND ASSAY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECOMBINANT PROTEINS; TRIAZINES; URACIL;

EID: 0030693165     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9702387     Document Type: Article

References (28)

1. Watkins, J. C.; Krogsgaard-Larsen, P.; Honoré, T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol. Sci. 1990, 11, 25-33.
2. Pin, J. P.; Duvoisin, R. The metabotropic glutamate receptors-structure and functions. Neuropharmaeology 1995, 34, 1-26.
3. Jane, D. E.; Olverman, H. J.; Watkins, J. C. Agonists and competitive antagonists: structure-activity and molecular modelling studies. In The NMDA Receptor, 2nd ed.; Collingridge, G. L., Watkins, J. C., Eds.; Oxford University Press: Oxford, U.K., 1994.
4. Fletcher, E. J.; Lodge, D. New developments in the molecular pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors. Pharmacol. Ther. 1996, 70, 65- 89.
5. Bettler, B.; Mulle, C. Neurotransmitter receptors. 2. AMPA and kainate receptors. Neuropharmacology 1995, 34, 123-139.
6. Jane, D. E.; Pook, P. C.-K.; Sunter, D. C.; Udvarhelyi, P. M.; Watkins, J. C. New willardiine analogs with potent stereoselective actions on mammalian spinal neurones. Br. Pharmacol. 1991, 104, 333P.
7. Blake, J. F.; Jane, D. E.; Watkins, J. C. Action of willardiine analogs on immature rat dorsal roots. Br. J. Pharmacol. 1991, 104, 334P.
8. Patneau, D. K.; Mayer, M. L.; Jane, D. E.; Watkins, J. C. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J. Neurosci. 1992, 12, 595-606.
9. Wong, L. A.; Mayer, M. L.; Jane, D. E.; Watkins, J. C. Willardiies differentiate agonist binding sites for kainate-versus AMPA-preferring glutamate receptors in DRG and hippocampal neurones. J. Neurosci. 1994, 14, 3881-3897.
10. 3H]-AMPA to rat-brain synaptic membranes - effects of a series of structural analogs of the non-NMDA receptor agonist willardiine. Neuropharmacology 1995, 34, 405-410.
11. 3H]-5-fluorowillardiine binding in rat brain. Br. J. Pharmacol. 1995, 116, 2033-2039.
12. Hawkins, L. M.; Jane, D. E.; Roberts, P. J. The effect of 6-aza substitution on the affinity of willardiine derivatives for the AMPA receptor. Br. J. Pharmacol. Proc. Suppl. 1995, 117, 332P.
13. Thompson, G. A.; Jane, D. E.; Watkins, J. C. Depolarising effects of certain derivatives of (S)-willardiine upon in vitro neonatal rat dorsal roots. Br. J. Pharmacol. Proc. Suppl. 1995, 117, 331P.
14. Pinkney, J. M.; Ahluwalia, P.; Kingston, W. P.; Pook, P. C.-K.; Jane, D. E.; Watkins, J. C. An electrophysiological study of 6-azawillardiine derivatives on mammalian spinal neurons Br J. Pharmacol. 1996, 118, 50P.
15. Dewar, J. H.; Shaw, G. Purines, pyrimidines and imidazoles. Part XVII. A synthesis of willardiine. J. Chem. Soc. 1962, 1, 583-585.
16. Martinez, A. P.; Lee, W. W. An improved synthesis of willardiine and l-(2′,2′-diethoxyethyl)uracil. J. Org. Chem. 1965, 317-318.
17. Doel, M. T.; Jones, A. S.; Taylor, N. An approach to the synthesis of peptide analogues of oligonucleotides (nucleopeptides), Tetrahedron Lett. 1969, 2285-2288.
18. Arnold, L. D.; Kalantar, T. H.; Vederas, J. C. Conversion of serine to stereochemically pure β-substituted α-amino acids via β-lactones. J. Am. Chem. Soc. 1985, 107, 7105-7109.
19. Ramer, S. E.; Moore, R. N.; Vederas, J. C. Mechanism of formation of serine-β-lactones. Can. J. Chem. 1986, 64, 706-713.
20. Arnold, L. D.; Drover, J. C. G.; Vederas, J. C. Conversion of serine-β-lactones to chiral α-amino acids by copper-containing organolithium and organomagnesium reagents. J. Am Chem. Soc. 1987, 109, 4649-4659.
21. Arnold, L. D.; May, R. G.; Vederas, J. C. Synthesis of optically pure α-amino acids via salts of α-amino-β-propiolactone. J. Am. Chem. Soc. 1988, 110, 2237-2241.
22. 1-Pyrimidyl)-2-aminobutyric acids. Tetrahedron 1968, 25, 5989-5994.
23. Jonas, J.; Gut, J. Nucleic acid components and their analogs XVI Dissociation constants of uracil, 6-azauracil, 5-azauracil and related compounds. Collect. Czech. Chem. Commun. 1962, 27, 716-723.
24. Chang, P. K. New 5-substituted 6-azauracils. J. Org. Chem. 1961, 1118-1120.
25. Korczak, B.; Nutt, S. L.; Fletcher, E. J.; Hoo, K. H.; Elliott, C. E.; Rampersad, V.; McWhinnie, E. A.; Kamboj, R. K. cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration. Receptors Channels 1995, 3, 41-49.
26. Hoo, K. H.; Nutt, S. L.; Fletcher, E. J.; Elliott, C. E.; Korczak B.; Devenu, R. M.; Rampersad, V.; Fantaske, R. P.; Kamboj, R. K. Functional expression and pharmacological characterization of the human EAA4 (GluR6) glutamate receptor: A kainate selective channel subunit. Receptors Channels 1994, 2, 327-337.
27. Kamboj, R.; Elliott, C.; Nutt, S. L. Amino-hydroxy-methyl-isoxazole-propionate binding human glutamate receptors. Eur. Pat. Appl. 93304500.7, 1993.
28. Fletcher, E. J.; Nutt, S. L.; Hoo, K. H.; Elliott, C. E.; Korczak, B.; McWhinnie, E. A., Kamboj, R. K. Cloning, expression and pharmacological characterization of a human glutamate receptor: hGluR4. Receptors Channels 1995, 3, 21-31.